05/09/2024
3:43 PM | Bioxytran (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
2:39 PM | Bioxytran (Filer)
| Form 10-Q/A | |
04/19/2024
3:50 PM | Bioxytran (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/19/2024
3:25 PM | Bioxytran (Issuer)
MILANOVA RADKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:26 PM | Bioxytran (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
3:21 PM | Bioxytran (Issuer)
Hoberman Alan M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:23 PM | Bioxytran (Issuer)
CONAWAY DALE H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/19/2024
1:46 PM | Bioxytran (Issuer)
MILANOVA RADKA (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:56 PM | Bioxytran (Issuer)
CONAWAY DALE H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:58 PM | Bioxytran (Issuer)
Utter Anders (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:48 PM | Bioxytran (Issuer)
Hoberman Alan M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | Bioxytran (Issuer)
PLATT DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:17 PM | Bioxytran (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/16/2024
9:00 AM | Bioxytran (Issuer)
PLATT DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
9:03 AM | Bioxytran (Issuer)
Hoberman Alan M (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/16/2024
9:06 AM | Bioxytran (Issuer)
CONAWAY DALE H (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/16/2024
9:09 AM | Bioxytran (Issuer)
Utter Anders (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/16/2024
8:53 AM | Bioxytran (Issuer)
Chen-Walden Hana (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
11/02/2023
8:02 PM | Bioxytran (Issuer)
Hoberman Alan M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
8:05 PM | Bioxytran (Issuer)
Utter Anders (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
8:07 PM | Bioxytran (Issuer)
CONAWAY DALE H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
5:34 AM | Bioxytran (Issuer)
Chen-Walden Hana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
10:36 AM | Bioxytran (Filer)
| Form 424B4 | |
10/01/2023
11:15 PM | Bioxytran (Filer)
| Form EFFECT | |
09/26/2023
4:04 PM | Bioxytran (Filer)
| Form S-1/A | |
09/21/2023
9:53 AM | Bioxytran (Filer)
| Form DEL AM | |
09/19/2023
12:05 PM | Bioxytran (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
09/15/2023
5:21 PM | Bioxytran (Issuer)
PLATT DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
2:06 PM | Bioxytran (Issuer)
Hoberman Alan M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
2:09 PM | Bioxytran (Issuer)
Utter Anders (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
2:11 PM | Bioxytran (Issuer)
CONAWAY DALE H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
2:15 PM | Bioxytran (Issuer)
PLATT DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
1:45 PM | Bioxytran (Issuer)
Chen-Walden Hana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
8:15 AM | Bioxytran (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
11:15 PM | Bioxytran (Filer)
| Form EFFECT | |
08/14/2023
7:07 PM | Bioxytran (Filer)
| Form 424B4 | |
08/08/2023
7:36 PM | Bioxytran (Filer)
| Form S-1/A | |
08/02/2023
8:32 PM | Bioxytran (Filer)
| Form S-1/A | |
07/31/2023
1:07 PM | Bioxytran (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/12/2023
6:19 PM | Bioxytran (Filer)
| Form S-1/A | |
07/07/2023
8:23 AM | Bioxytran (Filer)
| Form S-1/A | |
Biden Nomination CANCELED? (Ad) The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.”
Why is he all BUT guaranteed the Democratic nomination, in their words? I believe I have the terrifying answer right here. |
06/16/2023
6:01 AM | Bioxytran (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/12/2023
5:11 AM | Bioxytran (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
